FTLF on Nasdaq
FITLIFE BRANDS, INC.
American medicinal chemicals and botanical products company based in Omaha. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with MediWound Ltd., Bon Natural Life Ltd or Charlie's Holdings, Inc., or pick any stock.
- TickerFTLF on Nasdaq2
- IndustryMedicinal Chemicals & Botanical Products2
- HeadquartersOmaha, United States2
- Incorporated inNV3
- Business address5214 S. 136Th Street, Omaha, Ne 681373
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formProfit Corporation2
- LEI549300A8X02SIUSI3V402
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O VCORP SERVICES, LLC, 89701 Carson City, United States2
- Registered withBusiness Center (Secretary of State), E0513582005-72
See how the biggest companies compare on our leaderboards
FitLife Brands, Inc. (the “ Company ”) is a provider of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers marketed under the following brand names: (i) NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, the “ NDS Products ”); (ii) iSatori, BioGenetic Laboratories, and Energize (together, the " iSatori Products "); (iii) Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the “ MRC Products "); (iv) MusclePharm; and (v) Irwin Naturals, Applied Nutrition, and Nature’s Secret (together, the “ Irwin Products ”).4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
43.1%Gross margin5
18.6%Operating margin5
12.7%Net margin5
-75.3%Revenue growth, 20255
4.6%Return on equity6
$7.4MFree cash flow6
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Regions
United States brought in 95% of the revenue FITLIFE BRANDS, INC. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $61.5M | $77.4M |
| Outside the United States | $3.0M | $4.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue57¢$9.1M
- Selling, general and admin16¢$2.5M
- Other costs10¢$1.6M
- Income tax4¢$701.0K
- Profit13¢$2.0M
Out of $15.9M in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending1¢$42.0K
- Kept or used elsewhere99¢$7.4M
Out of $7.4M of cash from operations.6
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $81.5M | $64.5M |
| Cost of goods sold | $50.0M | $36.4M |
| Gross profit | $31.5M | $28.1M |
| Advertising and marketing | $4.9M | $4.6M |
| Selling, general and administrative | $14.0M | $10.0M |
| Merger and acquisition related | $2.1M | $255.0K |
| Depreciation and amortization | $420.0K | $108.0K |
| Total operating expense | $21.4M | $15.0M |
| OPERATING INCOME | $10.1M | $13.1M |
| Interest income | -$98.0K | -$69.0K |
| Interest expense | $1.9M | $1.4M |
| Other expense | $49.0K | $0 |
| Foreign exchange loss (gain) | $19.0K | -$50.0K |
| Total other expense, net | $1.8M | $1.2M |
| INCOME BEFORE INCOME TAX PROVISION | $8.2M | $11.9M |
| PROVISION FOR INCOME TAXES | $1.9M | $2.9M |
| NET INCOME | $6.3M | $9.0M |
| Basic (in dollars per share) | $0.68 | $0.98 |
| Diluted (in dollars per share) | $0.63 | $0.91 |
| Basic weighted average common shares (in shares) | 9.3M shares | 9.2M shares |
| Diluted weighted average common shares (in shares) | 10.0M shares | 9.9M shares |
| Foreign currency translation adjustment | $127.0K | -$370.0K |
| Loss on derivatives | -$26.0K | $0 |
| Comprehensive income | $6.4M | $8.6M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.6M | $4.5M | ||
| Restricted cash | $0 | $52.0K | ||
| Accounts receivable, net of allowance for credit losses of $9 and $41, respectively | $8.8M | $1.6M | ||
| Inventories, net of allowance for obsolescence of $247 and $100, respectively | $21.3M | $11.1M | ||
| Prepaid expense and other current assets | $1.3M | $923.0K | ||
| Total current assets | $33.1M | $18.1M | ||
| Property and equipment, net | $128.0K | $75.0K | ||
| Right of use asset | $682.0K | $412.0K | ||
| Intangibles, net of amortization of $500 and $152, respectively | $51.4M | $26.2M | ||
| Goodwill | $19.4M | $13.0M | ||
| Deferred tax asset | $1.5M | $644.0K | ||
| Other assets | $83.0K | $0 | ||
| TOTAL ASSETS | $106.3M | $58.5M | ||
| Accounts payable | $6.9M | $4.1M | ||
| Accrued expense | $5.4M | $684.0K | ||
| Income taxes payable | $1.7M | $1.4M | ||
| Product returns | $1.0M | $564.0K | ||
| Term loan current portion | $6.1M | $4.5M | ||
| Lease liability current portion | $433.0K | $81.0K | ||
| Total current liabilities | $21.6M | $11.3M | ||
| Revolving line of credit | $5.6M | $0 | ||
| Term loan, net of current portion and unamortized deferred finance costs | $32.8M | $8.6M | ||
| Long-term lease liability, net of current portion | $272.0K | $331.0K | ||
| Derivative liability | $26.0K | $0 | ||
| Deferred tax liability | $2.3M | $2.2M | ||
| TOTAL LIABILITIES | $62.7M | $22.4M | ||
| Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.01 par value, 120,000 shares authorized; 9,391 and 9,210 issued and outstanding as of December 31, 2025 and 2024 | $94.0K | $92.0K | ||
| Additional paid-in capital | $32.2M | $31.1M | ||
| Retained earnings | $11.9M | $5.6M | ||
| Accumulated other comprehensive loss | -$561.0K | -$662.0K | ||
| TOTAL STOCKHOLDERS' EQUITY | $43.6M | $36.1M | $27.0M | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $106.3M | $58.5M | ||
| Allowance of doubtful accounts | $9.0K | $41.0K | ||
| Allowance for obsolescence | $247.0K | $100.0K | ||
| Intangibles amortization | $499.0K | $152.0K | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 120.0M shares | 120.0M shares | 120.0M shares | |
| Common stock, shares issued (in shares) | 9.4M shares | 9.2M shares | ||
| Common stock, shares outstanding (in shares) | 9.4M shares | 9.2M shares |
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.6M | $4.5M | ||
| Restricted cash | $0 | $52.0K | ||
| Accounts receivable, net of allowance for credit losses of $9 and $41, respectively | $8.8M | $1.6M | ||
| Inventories, net of allowance for obsolescence of $247 and $100, respectively | $21.3M | $11.1M | ||
| Prepaid expense and other current assets | $1.3M | $923.0K | ||
| Total current assets | $33.1M | $18.1M | ||
| Property and equipment, net | $128.0K | $75.0K | ||
| Right of use asset | $682.0K | $412.0K | ||
| Intangibles, net of amortization of $500 and $152, respectively | $51.4M | $26.2M | ||
| Goodwill | $19.4M | $13.0M | ||
| Deferred tax asset | $1.5M | $644.0K | ||
| Other assets | $83.0K | $0 | ||
| TOTAL ASSETS | $106.3M | $58.5M | ||
| Accounts payable | $6.9M | $4.1M | ||
| Accrued expense | $5.4M | $684.0K | ||
| Income taxes payable | $1.7M | $1.4M | ||
| Product returns | $1.0M | $564.0K | ||
| Term loan current portion | $6.1M | $4.5M | ||
| Lease liability current portion | $433.0K | $81.0K | ||
| Total current liabilities | $21.6M | $11.3M | ||
| Revolving line of credit | $5.6M | $0 | ||
| Term loan, net of current portion and unamortized deferred finance costs | $32.8M | $8.6M | ||
| Long-term lease liability, net of current portion | $272.0K | $331.0K | ||
| Derivative liability | $26.0K | $0 | ||
| Deferred tax liability | $2.3M | $2.2M | ||
| TOTAL LIABILITIES | $62.7M | $22.4M | ||
| Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock, $0.01 par value, 120,000 shares authorized; 9,391 and 9,210 issued and outstanding as of December 31, 2025 and 2024 | $94.0K | $92.0K | ||
| Additional paid-in capital | $32.2M | $31.1M | ||
| Retained earnings | $11.9M | $5.6M | ||
| Accumulated other comprehensive loss | -$561.0K | -$662.0K | ||
| TOTAL STOCKHOLDERS' EQUITY | $43.6M | $36.1M | $27.0M | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $106.3M | $58.5M | ||
| Allowance of doubtful accounts | $9.0K | $41.0K | ||
| Allowance for obsolescence | $247.0K | $100.0K | ||
| Intangibles amortization | $499.0K | $152.0K | ||
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 120.0M shares | 120.0M shares | 120.0M shares | |
| Common stock, shares issued (in shares) | 9.4M shares | 9.2M shares | ||
| Common stock, shares outstanding (in shares) | 9.4M shares | 9.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| NET INCOME | $6.3M | $9.0M |
| Depreciation and amortization | $420.0K | $108.0K |
| Allowance for credit losses | -$32.0K | $24.0K |
| Allowance for inventory obsolescence | $147.0K | -$62.0K |
| Stock-based compensation | $404.0K | $459.0K |
| Amortization of deferred financing costs | $40.0K | $41.0K |
| Write-off of deferred financing costs | $49.0K | $0 |
| Amortization of inventory step-up | $1.0M | $0 |
| Accounts receivable - trade | $210.0K | $361.0K |
| Inventories | -$582.0K | -$2.1M |
| Deferred taxes | -$881.0K | $148.0K |
| Prepaid expense and other assets | $200.0K | $692.0K |
| Right-of-use asset | $242.0K | $90.0K |
| Accounts payable | $743.0K | $866.0K |
| Income taxes payable | -$54.0K | $634.0K |
| Lease liability | -$223.0K | -$107.0K |
| Accrued expense and other current liabilities | -$582.0K | -$512.0K |
| Product returns | -$33.0K | -$7.0K |
| Net cash provided by operating activities | $7.4M | $9.6M |
| Purchase of property and equipment | -$42.0K | -$10.0K |
| Net cash used in investing activities | -$42.5M | -$10.0K |
| Proceeds from exercise of stock options | $682.0K | $17.0K |
| Borrowings on term loans | $40.5M | $0 |
| Payoff of 2023 term loans | -$10.9M | $0 |
| Borrowings on line of credit | $5.6M | $0 |
| Net cash provided by (used in) financing activities | $32.1M | -$7.0M |
| Foreign currency impact on cash | $143.0K | $5.0K |
| CHANGE IN CASH AND RESTRICTED CASH | -$2.9M | $2.6M |
| Cash paid for income taxes | $2.4M | $2.5M |
| Cash paid for interest, net of amounts capitalized | $1.7M | $1.4M |
| Addition to right-of-use assets from new operating lease liabilities | $0 | $386.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led FITLIFE BRANDS, INC., and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
201520202025
- Chief executive officerJudd Dayton Mar 22, 2018 to now14
- Chief executive officerStephen D. Adele Feb 18, 2016 to Feb 18, 201615
- Chief executive officerJohn S. Wilson Sep 1, 2010 to Feb 25, 201516
- PresidentRyan P. Hansen May 19, 2026 to now17
- Chief financial officerJakob York Aug 15, 2022 to now18
- Chief financial officerSusan Kinnaman Feb 25, 2019 to Apr 20, 202119
- Chief financial officerMichael S. Abrams Aug 30, 2010 to Feb 14, 201720
Board members and other officers (15)
- Executive Vice PresidentRyan P. Hansen May 12, 2025 to now21
- Chief Retail OfficerPatrick John Phillip Ryan Jan 11, 2023 to Jun 4, 202422
- Board memberShannon K. Pappas May 12, 2025 to now23
- Board memberMatthew Lingenbrink Aug 14, 2024 to now24
- Board memberJudd Dayton Jun 30, 2017 to now25
- Board memberStephen D. Adele Feb 18, 2016 to Feb 18, 201615
- Board memberSeth Yakatan Oct 19, 2015 to now26
- Board memberTodd Ordal Oct 19, 2015 to now27
- Board memberGrant Robert Dawson Nov 8, 2013 to now28
- Board memberFadi M. Aramouni Dec 5, 2013 to Oct 21, 201529
- Board memberLewis Jaffe Jan 13, 2011 to Oct 20, 202030
- Board memberMichael S. Abrams Mar 30, 2011 to Feb 14, 201731
- Board memberJohn S. Wilson Sep 1, 2010 to Feb 25, 201516
- Board memberElorian Connard Landers Sep 13, 2010 to Jan 3, 201132
- Board memberScott D. Landow Nov 24, 2010 to Nov 24, 201033
Former names
- BOND LABORATORIES, INC.Sep 7, 2006 to Oct 1, 20133
Timeline
Filings
123 filings to the SEC since October 2021: 10 annual reports, 15 quarterly reports, 47 major events, 30 insider forms, 3 large holders, 18 other. The latest 20:
- Sep 9, 20268-K EDGAR
- Sep 2, 20264 EDGAR
- Aug 21, 20264 EDGAR
- Aug 13, 20268-K EDGAR
- Aug 13, 202610-Q EDGAR
- Aug 7, 2026SCHEDULE 13G/A EDGAR
- Jun 26, 2026DEFA14A EDGAR
- Jun 26, 2026DEFA14A EDGAR
- Jun 26, 2026DEF 14A EDGAR
- May 22, 20268-K EDGAR
- May 19, 20264 EDGAR
- May 14, 20268-K EDGAR
- May 14, 202610-Q EDGAR
- Apr 21, 202610-K/A EDGAR
- Apr 20, 20264 EDGAR
- Apr 20, 20265 EDGAR
- Apr 14, 20264 EDGAR
- Apr 14, 20264 EDGAR
- Apr 7, 20268-K EDGAR
- Apr 1, 20268-K EDGAR
The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
15 open-market trades by officers, directors and large owners since October 2021: 12 buys and 3 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Pappas Shannon K.Director | Buy | 1,000 | $10.25 | $10.2K | Form 4 |
| Apr 10, 2026 | Lingenbrink MatthewDirector | Buy | 3,000 | $9.76 | $29.3K | Form 4 |
| Apr 10, 2026 | Dawson Grant RobertDirector | Buy | 3,000 | $9.98 | $29.9K | Form 4 |
| Jan 15, 2026 | Yakatan SethDirector | Buy | 164 | $15.36 | $2.5K | Form 4 |
| Dec 15, 2025 | Yakatan SethDirector | Buy | 139 | $18.31 | $2.5K | Form 4 |
| Sep 15, 2025 | Yakatan SethDirector | Buy | 142 | $17.87 | $2.5K | Form 4 |
| Aug 25, 2025 | Yakatan SethDirector | Buy | 148 | $17.00 | $2.5K | Form 4 |
| Apr 15, 2025 | Ordal ToddDirector | Buy | 300 | $12.07 | $3.6K | Form 4 |
| Apr 14, 2025 | Lingenbrink MatthewDirector | Buy | 3,000 | $12.17 | $36.5K | Form 4 |
| Mar 31, 2025 | Lingenbrink MatthewDirector | Buy | 2,800 | $12.17 | $34.1K | Form 4 |
| Jan 15, 2025 | Ordal ToddDirector | Buy | 150 | $30.37 | $4.6K | Form 4 |
| Jun 3, 2024 | Ryan Patrick John PhillipCHIEF RETAIL OFFICER | Sale | 6,544 | $32.29 | $211.3K | Form 4 |
| May 31, 2024 | Ryan Patrick John PhillipCHIEF RETAIL OFFICER | Sale | 4,000 | $31.00 | $124.0K | Form 4 |
| Dec 15, 2023 | Ryan Patrick John PhillipCHIEF RETAIL OFFICER | Sale | 4,000 | $24.50 | $98.0K | Form 4 |
| May 18, 2023 | York JakobCHIEF FINANCIAL OFFICER | Buy | 1,000 | $17.00 | $17.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- ASKELADDEN CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 3 filings Jan 17, 2025 to Aug 7, 202634
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 42. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARJudd Dayton, Chief executive officer
- 15
- 16
- 17SEC EDGARRyan P. Hansen, President
- 18SEC EDGARJakob York, Chief financial officer
- 19
- 20
- 21
- 22
- 23SEC EDGARShannon K. Pappas, Board member
- 24SEC EDGARMatthew Lingenbrink, Board member
- 25SEC EDGARJudd Dayton, Board member
- 26SEC EDGARSeth Yakatan, Board member
- 27SEC EDGARTodd Ordal, Board member
- 28SEC EDGARGrant Robert Dawson, Board member
- 29SEC EDGARFadi M. Aramouni, Board member
- 30SEC EDGARLewis Jaffe, Board member
- 31SEC EDGARMichael S. Abrams, Board member
- 32
- 33SEC EDGARScott D. Landow, Board member
- 34